These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36750607)

  • 1. Using optimal controlled singlet spin order to accurately target molecular signal in MRI and MRS.
    Xin JX; Yang G; Zhang H; Li J; Fu C; Wang J; Tong R; Ren Y; Wei DX; Yao YF
    Sci Rep; 2023 Feb; 13(1):2212. PubMed ID: 36750607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a fused phantom for quantitative evaluation of brain metabolites and enhanced quality assurance testing for magnetic resonance imaging and spectroscopy.
    Song KH; Kim SY; Lee DW; Jung JY; Lee JH; Baek HM; Choe BY
    J Neurosci Methods; 2015 Nov; 255():75-84. PubMed ID: 26277420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-targeting NMR signal selection by optimal control of nuclear spin singlet.
    Yang X; Hu KR; Xin JX; Li YX; Yang G; Wei DX; Yao YF
    J Magn Reson; 2022 May; 338():107188. PubMed ID: 35338893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing glutamate and glutamine in in vivo
    Xin JX; Wei DX; Ren Y; Wang JL; Yang G; Zhang H; Li J; Fu C; Yao YF
    Magn Reson Med; 2023 May; 89(5):1728-1740. PubMed ID: 36572961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying neonatal bilirubin encephalopathy with conventional MRI, MRS, and DWI.
    Wang X; Wu W; Hou BL; Zhang P; Chineah A; Liu F; Liao W
    Neuroradiology; 2008 Oct; 50(10):885-93. PubMed ID: 18563403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.
    Broom KA; Anthony DC; Lowe JP; Griffin JL; Scott H; Blamire AM; Styles P; Perry VH; Sibson NR
    Neurobiol Dis; 2007 Jun; 26(3):707-17. PubMed ID: 17490889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease.
    Alkhalik Basha MA; Refaat R; Ahmed AF; Yousef HY; Alsowey AM; Metwally MI; Aly SA; Hussien HM; El-Saadany HF; AlGhobashy AA; Talat MA; Amer MM; Eid AM
    Eur J Radiol; 2019 Feb; 111():41-46. PubMed ID: 30691663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and applications of in vivo clinical magnetic resonance spectroscopy.
    Cox IJ
    Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease.
    Varho T; Komu M; Sonninen P; Holopainen I; Nyman S; Manner T; Sillanpää M; Aula P; Lundbom N
    Neurology; 1999 May; 52(8):1668-72. PubMed ID: 10331697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro singlet state and zero-quantum encoded magnetic resonance spectroscopy: Illustration with N-acetyl-aspartate.
    Pravdivtsev AN; Sönnichsen FD; Hövener JB
    PLoS One; 2020; 15(10):e0239982. PubMed ID: 33002045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Detection of Perinatal Brain Metabolite Changes in a Rabbit Model of Intrauterine Growth Restriction (IUGR).
    Simões RV; Muñoz-Moreno E; Carbajo RJ; González-Tendero A; Illa M; Sanz-Cortés M; Pineda-Lucena A; Gratacós E
    PLoS One; 2015; 10(7):e0131310. PubMed ID: 26208165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy.
    Gujar SK; Maheshwari S; Björkman-Burtscher I; Sundgren PC
    J Neuroophthalmol; 2005 Sep; 25(3):217-26. PubMed ID: 16148633
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Bhogal AA; Schür RR; Houtepen LC; van de Bank B; Boer VO; Marsman A; Barker PB; Scheenen TWJ; Wijnen JP; Vinkers CH; Klomp DWJ
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28915314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study.
    Klär AA; Ballmaier M; Leopold K; Häke I; Schaefer M; Brühl R; Schubert F; Gallinat J
    Neuroimage; 2010 Oct; 53(1):51-7. PubMed ID: 20541020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.
    Castellino G; Govoni M; Padovan M; Colamussi P; Borrelli M; Trotta F
    Ann Rheum Dis; 2005 Jul; 64(7):1022-7. PubMed ID: 15640271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
    Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
    NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.
    Lotumolo A; Caivano R; Rabasco P; Iannelli G; Villonio A; D' Antuono F; Gioioso M; Zandolino A; Macarini L; Guglielmi G; Cammarota A
    Eur J Radiol; 2015 Dec; 84(12):2597-604. PubMed ID: 26391231
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.